New anesthetic may keep blood pressure steadier during stroke clot removal

NCT ID NCT07696208

Not yet recruiting Disease control Sponsor: RenJi Hospital Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial tests whether ciprofol, a newer anesthetic, can keep blood pressure more stable than the standard drug propofol in people having general anesthesia for endovascular thrombectomy after an ischemic stroke. Stable blood pressure during the procedure may improve outcomes. The study involves 124 adults with acute ischemic stroke who are eligible for clot removal surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ciprofol
What this could lead to: If ciprofol proves better at maintaining stable blood pressure during stroke surgery, it could become a preferred anesthetic for these procedures, potentially improving recovery.
What could go wrong: This is a relatively small, open-label trial, so results may not be definitive. Ciprofol's benefits over propofol are not yet proven, and individual responses vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMODYNAMIC STABILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMODYNAMIC STABILITY ISCHEMIC STROKES

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shanghai Jiaotong University School of Medicine

Shanghai, Pudong New Area, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.